These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22177033)

  • 1. Antagonistic regulation of transmembrane 4 L6 family member 5 attenuates fibrotic phenotypes in CCl(4) -treated mice.
    Kang M; Jeong SJ; Park SY; Lee HJ; Kim HJ; Park KH; Ye SK; Kim SH; Lee JW
    FEBS J; 2012 Feb; 279(4):625-35. PubMed ID: 22177033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-talk between TGFβ1 and EGFR signalling pathways induces TM4SF5 expression and epithelial-mesenchymal transition.
    Kang M; Choi S; Jeong SJ; Lee SA; Kwak TK; Kim H; Jung O; Lee MS; Ko Y; Ryu J; Choi YJ; Jeong D; Lee HJ; Ye SK; Kim SH; Lee JW
    Biochem J; 2012 May; 443(3):691-700. PubMed ID: 22292774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of four-transmembrane L6 family member 5 (TM4SF5)-mediated tumorigenicity in hepatocytes by a synthetic chalcone derivative.
    Lee SA; Ryu HW; Kim YM; Choi S; Lee MJ; Kwak TK; Kim HJ; Cho M; Park KH; Lee JW
    Hepatology; 2009 Apr; 49(4):1316-25. PubMed ID: 19177595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib.
    Deng YR; Ma HD; Tsuneyama K; Yang W; Wang YH; Lu FT; Liu CH; Liu P; He XS; Diehl AM; Gershwin ME; Lian ZX
    J Autoimmun; 2013 Oct; 46():25-34. PubMed ID: 23948302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-β1 induced epithelial-mesenchymal transition in hepatic fibrosis.
    Bi WR; Yang CQ; Shi Q
    Hepatogastroenterology; 2012 Sep; 59(118):1960-3. PubMed ID: 22369740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TM4SF5-Mediated Roles in the Development of Fibrotic Phenotypes.
    Ryu J; Lee JW
    Mediators Inflamm; 2017; 2017():5108525. PubMed ID: 28458469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations between transmembrane 4 L6 family member 5 (TM4SF5), CD151, and CD63 in liver fibrotic phenotypes and hepatic migration and invasive capacities.
    Kang M; Ryu J; Lee D; Lee MS; Kim HJ; Nam SH; Song HE; Choi J; Lee GH; Kim TY; Lee H; Kim SJ; Ye SK; Kim S; Lee JW
    PLoS One; 2014; 9(7):e102817. PubMed ID: 25033048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage.
    Dooley S; Hamzavi J; Ciuclan L; Godoy P; Ilkavets I; Ehnert S; Ueberham E; Gebhardt R; Kanzler S; Geier A; Breitkopf K; Weng H; Mertens PR
    Gastroenterology; 2008 Aug; 135(2):642-59. PubMed ID: 18602923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cholinergic denervation on hepatic fibrosis induced by carbon tetrachloride in rats.
    Lam HB; Yeh CH; Cheng KC; Hsu CT; Cheng JT
    Neurosci Lett; 2008 Jun; 438(1):90-5. PubMed ID: 18472332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis.
    Perugorria MJ; Latasa MU; Nicou A; Cartagena-Lirola H; Castillo J; Goñi S; Vespasiani-Gentilucci U; Zagami MG; Lotersztajn S; Prieto J; Berasain C; Avila MA
    Hepatology; 2008 Oct; 48(4):1251-61. PubMed ID: 18634036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxysafflor yellow A protects against chronic carbon tetrachloride-induced liver fibrosis.
    Zhang Y; Guo J; Dong H; Zhao X; Zhou L; Li X; Liu J; Niu Y
    Eur J Pharmacol; 2011 Jun; 660(2-3):438-44. PubMed ID: 21536026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of hepatoma-derived growth factor is involved in murine hepatic fibrogenesis.
    Kao YH; Chen CL; Jawan B; Chung YH; Sun CK; Kuo SM; Hu TH; Lin YC; Chan HH; Cheng KH; Wu DC; Goto S; Cheng YF; Chao D; Tai MH
    J Hepatol; 2010 Jan; 52(1):96-105. PubMed ID: 19913322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic efficacy of Traditional Chinese Medicine 319 recipe on hepatic fibrosis induced by carbon tetrachloride in rats.
    Cheung KF; Ye DW; Yang ZF; Lu L; Liu CH; Wang XL; Poon RT; Tong Y; Liu P; Chen YC; Lau GK
    J Ethnopharmacol; 2009 Jul; 124(1):142-50. PubMed ID: 19501992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C/EBP-α ameliorates CCl(4)-induced liver fibrosis in mice through promoting apoptosis of hepatic stellate cells with little apoptotic effect on hepatocytes in vitro and in vivo.
    Tao LL; Cheng YY; Ding D; Mei S; Xu JW; Yu J; Ou-Yang Q; Deng L; Chen Q; Li QQ; Xu ZD; Liu XP
    Apoptosis; 2012 May; 17(5):492-502. PubMed ID: 22307857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apamin inhibits hepatic fibrosis through suppression of transforming growth factor β1-induced hepatocyte epithelial-mesenchymal transition.
    Lee WR; Kim KH; An HJ; Kim JY; Lee SJ; Han SM; Pak SC; Park KK
    Biochem Biophys Res Commun; 2014 Jul; 450(1):195-201. PubMed ID: 24878534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamine inhibits CCl4 induced liver fibrosis in mice and TGF-β1 mediated epithelial-mesenchymal transition in mouse hepatocytes.
    Shrestha N; Chand L; Han MK; Lee SO; Kim CY; Jeong YJ
    Food Chem Toxicol; 2016 Jul; 93():129-37. PubMed ID: 27137983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice.
    Latella G; Vetuschi A; Sferra R; Catitti V; D'Angelo A; Zanninelli G; Flanders KC; Gaudio E
    Liver Int; 2009 Aug; 29(7):997-1009. PubMed ID: 19422482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of NK2 promotes liver fibrosis in carbon tetrachloride-induced chronic liver injury.
    Hagiwara S; Otsuka T; Yamazaki Y; Kosone T; Sohara N; Ichikawa T; Sato K; Kakizaki S; Takagi H; Mori M
    Liver Int; 2008 Jan; 28(1):126-31. PubMed ID: 17976157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of CCl4-induced liver cirrhosis by ribbon antisense to transforming growth factor-beta1.
    Doh KO; Jung HK; Moon IJ; Kang HG; Park JH; Park JG
    Int J Mol Med; 2008 Jan; 21(1):33-9. PubMed ID: 18097613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase inhibition suppresses the transforming growth factor beta1-induced epithelial-to-mesenchymal transition in hepatocytes.
    Kaimori A; Potter JJ; Choti M; Ding Z; Mezey E; Koteish AA
    Hepatology; 2010 Sep; 52(3):1033-45. PubMed ID: 20564330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.